Dianthus Therapeutics, Inc. (DNTH)
106.57
+0.96
(+0.91%)
USD |
NASDAQ |
Sep 01, 14:05
Dianthus Therapeutics Cash from Operations (TTM) : -155.38M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -155.38M |
| March 31, 2026 | -130.29M |
| December 31, 2025 | -129.06M |
| September 30, 2025 | -109.52M |
| June 30, 2025 | -100.23M |
| March 31, 2025 | -90.87M |
| December 31, 2024 | -78.18M |
| September 30, 2024 | -62.59M |
| June 30, 2024 | -51.32M |
| March 31, 2024 | -41.52M |
| December 31, 2023 | -36.86M |
| September 30, 2023 | -33.86M |
| June 30, 2023 | -7.491M |
| March 31, 2023 | -19.61M |
| December 31, 2022 | -29.07M |
| September 30, 2022 | -35.91M |
| June 30, 2022 | -66.35M |
| March 31, 2022 | -62.50M |
| Date | Value |
|---|---|
| December 31, 2021 | -59.53M |
| September 30, 2021 | -57.57M |
| June 30, 2021 | -57.94M |
| March 31, 2021 | -64.14M |
| December 31, 2020 | -64.02M |
| September 30, 2020 | -65.92M |
| June 30, 2020 | -63.00M |
| March 31, 2020 | -58.82M |
| December 31, 2019 | -57.10M |
| September 30, 2019 | -54.10M |
| June 30, 2019 | -53.14M |
| March 31, 2019 | -47.22M |
| December 31, 2018 | -41.89M |
| September 30, 2018 | -37.49M |
| June 30, 2018 | -32.39M |
| March 31, 2018 | -27.84M |
| December 31, 2017 | -22.26M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Legend Biotech Corp. | -182.95M |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Verastem, Inc. | -162.20M |
| Fortress Biotech, Inc. | 120.36M |
| AbbVie, Inc. | 19.51B |